RecruitingNCT07309029

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Atlantic Health System
Intervention
Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO)(device)
Enrollment
30 enrolled
Eligibility
18-100 years · All sexes
Timeline
2026 – 2027

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07309029 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock →

← Back to all trials